{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:46:40Z","timestamp":1787662000701,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"DOI":"10.1007\/s40199-023-00481-z","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T18:02:02Z","timestamp":1697565722000},"page":"259-266","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Utilization patterns of cardiovascular medications in patients with diabetes mellitus; a retrospective cross-sectional study, 2013-17"],"prefix":"10.1007","volume":"31","author":[{"given":"Negin","family":"Hatami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad-Reza","family":"Malekpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Farzadfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meysam","family":"Seyedifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6920-8796","authenticated-orcid":false,"given":"Fatemeh","family":"Soleymani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,17]]},"reference":[{"key":"481_CR1","volume-title":"IDF Diabetes Atlas","author":"International Diabetes Federation","year":"2021","unstructured":"International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels, Belgium: International Diabetes Federation; 2021.","edition":"10"},{"issue":"1","key":"481_CR2","doi-asserted-by":"publisher","first-page":"13528","DOI":"10.1038\/s41598-023-39433-7","volume":"13","author":"S Azadnajafabad","year":"2023","unstructured":"Azadnajafabad S, Ahmadi N, Rezaei N, Rashidi M-M, Saeedi Moghaddam S, Mohammadi E, et al. Evaluation of the diabetes care cascade and compliance with WHO global coverage targets in Iran based on STEPS survey 2021. Sci Rep. 2023;13(1):13528.","journal-title":"Sci Rep"},{"issue":"9","key":"481_CR3","doi-asserted-by":"publisher","first-page":"A475","DOI":"10.1016\/j.jval.2017.08.435","volume":"20","author":"A Acs","year":"2017","unstructured":"Acs A, Ludwig C, Bereza BG, Einarson TR, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: A global systematic review. Value Health. 2017;20(9):A475.","journal-title":"Value Health"},{"issue":"24","key":"481_CR4","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1161\/CIRCULATIONAHA.116.022194","volume":"133","author":"CC Low Wang","year":"2016","unstructured":"Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes Mellitus - mechanisms, management, and clinical considerations. Circulation. 2016;133(24):2459\u2013502.","journal-title":"Circulation"},{"issue":"7","key":"481_CR5","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.jacc.2017.07.001","volume":"70","author":"JD Newman","year":"2017","unstructured":"Newman JD, Schwartzbard AZ, Weintraub HS, Goldberg IJ, Berger JS. Primary Prevention of cardiovascular disease in diabetes mellitus. J Am Coll Cardiol. 2017;70(7):883\u201393.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"481_CR6","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.jval.2017.12.019","volume":"21","author":"TR Einarson","year":"2018","unstructured":"Einarson TR, Acs A, Ludwig C, Panton UH. Economic burden of cardiovascular disease in Type 2 diabetes: a systematic review. Value in Health. 2018;21(7):881\u201390.","journal-title":"Value in Health"},{"issue":"7","key":"481_CR7","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.amjcard.2019.07.002","volume":"124","author":"AM Chamberlain","year":"2019","unstructured":"Chamberlain AM, Cohen SS, Killian JM, Monda KL, Weston SA, Okerson T. Lipid-lowering prescription patterns in patients with diabetes mellitus or cardiovascular disease. Am J Cardiol. 2019;124(7):995\u20131001.","journal-title":"Am J Cardiol"},{"key":"481_CR8","doi-asserted-by":"publisher","first-page":"520915","DOI":"10.1155\/2012\/520915","volume":"2012","author":"E Dhanaraj","year":"2012","unstructured":"Dhanaraj E, Raval A, Yadav R, Bhansali A, Tiwari P. Prescription pattern of Antihypertensive Agents in T2DM patients visiting Tertiary Care Centre in North India. Int J Hypertens. 2012;2012:520915.","journal-title":"Int J Hypertens"},{"issue":"10258","key":"481_CR9","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"T Vos","year":"2020","unstructured":"Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204\u201322.","journal-title":"Lancet"},{"key":"481_CR10","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment, 2023. Oslo; 2022."},{"issue":"Supplement1","key":"481_CR11","first-page":"144","volume":"45","author":"American Diabetes Association Professional Practice C","year":"2021","unstructured":"American Diabetes Association Professional Practice C. 10. Cardiovascular disease and risk management: standards of medical care in diabetes\u20142022. Diabetes Care. 2021;45(Supplement1):144\u2013S174.","journal-title":"Diabetes Care"},{"key":"481_CR12","doi-asserted-by":"crossref","unstructured":"Marx N, Federici M, Sch\u00fctt K, M\u00fcller-Wieland D, Ajjan RA, Antunes MJ et al. 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the european society of cardiology (ESC). Eur Heart J. 2023. [Epub ahead of print]","DOI":"10.1007\/s00059-023-05218-x"},{"issue":"34","key":"481_CR13","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FLJ Visseren","year":"2021","unstructured":"Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, B\u00e4ck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies with the special contribution of the European Association of Preventive Cardiology (EAPC). Eur Heart J. 2021;42(34):3227\u2013337.","journal-title":"Eur Heart J"},{"key":"481_CR14","unstructured":"Pharmaceutical statistical database 2016. FDA. https:\/\/Fda.gov.ir\/.\u00a0Accessed 12 Oct 2020."},{"key":"481_CR15","unstructured":"World Health Organization. Noncommunicable D. Mental Health Cluster. Surveillance T. STEPS instruments for NCD risk factors (core and expanded version 1.4): the WHO STEPwise approach to Surveillance of noncommunicable diseases (STEPS). Geneva: World Health Organization; 2001."},{"key":"481_CR16","unstructured":"Djalalinia S, Modirian M, Sheidaei A, Yoosefi M, Zokaiee H, Damirchilu B, et al. Protocol design for large\u2013scale cross\u2013sectional studies of surveillance of risk factors of non\u2013communicable diseases in Iran: STEPs 2016. Arch Iran Med. 2017;20(9)."},{"key":"481_CR17","doi-asserted-by":"crossref","unstructured":"Veeramani V, Muraleedharan A. Study on drug utilization pattern in cardiology outpatient department at tertiary care hospitals in South India: a prospective multicenter cross-sectional observational study. 2020.","DOI":"10.5455\/ijmsph.2020.05080202003062020"},{"issue":"5","key":"481_CR18","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4103\/ijp.IJP_743_17","volume":"51","author":"C Naliganti","year":"2019","unstructured":"Naliganti C, Valupadas C, Akkinepally RR, Eesam S. Evaluation of drug utilization in cardiovascular disease at a teaching and referral hospital in Northern Telangana. Indian J Pharmacol. 2019;51(5):323\u20139.","journal-title":"Indian J Pharmacol"},{"issue":"1","key":"481_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1161\/HYPERTENSIONAHA.117.09259","volume":"70","author":"T Tsujimoto","year":"2017","unstructured":"Tsujimoto T, Sugiyama T, Shapiro MF, Noda M, Kajio H. Risk of cardiovascular events in patients with diabetes mellitus on \u03b2-blockers. Hypertension. 2017;70(1):103\u201310.","journal-title":"Hypertension"},{"issue":"16","key":"481_CR20","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1056\/NEJMoa1804988","volume":"379","author":"Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus","year":"2018","unstructured":"Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus. N Engl J Med. 2018;379(16):1529\u201339.","journal-title":"N Engl J Med"},{"issue":"22","key":"481_CR21","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1001\/archinte.159.22.2661","volume":"159","author":"SM Haffner","year":"1999","unstructured":"Haffner SM, Alexander CM, Cook TJ, Boccuzzi SJ, Musliner TA, Pedersen TR, et al. Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the scandinavian simvastatin survival study. Arch Intern Med. 1999;159(22):2661\u20137.","journal-title":"Arch Intern Med"},{"issue":"9435","key":"481_CR22","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","volume":"364","author":"HM Colhoun","year":"2004","unstructured":"Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil W, Livingstone HA. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the collaborative atorvastatin diabetes study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 2004;364(9435):685\u201396.","journal-title":"Lancet"},{"issue":"5","key":"481_CR23","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1001\/jamainternmed.2014.348","volume":"174","author":"J Cheng","year":"2014","unstructured":"Cheng J, Zhang W, Zhang X, Han F, Li X, He X, et al. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause Mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a Meta-analysis. JAMA Intern Med. 2014;174(5):773\u201385.","journal-title":"JAMA Intern Med"},{"issue":"2","key":"481_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.7326\/0003-4819-118-2-199301150-00009","volume":"118","author":"BL Kasiske","year":"1993","unstructured":"Kasiske BL, Kalil RS, Ma JZ, Liao M, Keane WF. Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med. 1993;118(2):129\u201338.","journal-title":"Ann Intern Med"},{"issue":"1","key":"481_CR25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1046\/j.1523-1755.2001.00790.x","volume":"60","author":"H-H Parving","year":"2001","unstructured":"Parving H-H, Hommel E, Jensen BR, Hansen HP. Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients. Kidney Int. 2001;60(1):228\u201334.","journal-title":"Kidney Int"},{"issue":"12","key":"481_CR26","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/NEJMoa011161","volume":"345","author":"BM Brenner","year":"2001","unstructured":"Brenner BM, Cooper ME, De Zeeuw D, Keane WF, Mitch WE, Parving H-H, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345(12):861\u20139.","journal-title":"N Engl J Med"},{"issue":"5","key":"481_CR27","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1161\/HYPERTENSIONAHA.120.16402","volume":"77","author":"S Chan You","year":"2021","unstructured":"Chan You S, Krumholz HM, Suchard MA, Schuemie MJ, Hripcsak G, Chen R, et al. Comprehensive comparative effectiveness and safety of first-line \u03b2-blocker monotherapy in hypertensive patients: a large-scale multicenter observational study. Hypertension (Dallas, Tex: 1979). 2021;77(5):1528\u201338.","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"issue":"2","key":"481_CR28","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s12020-023-03401-y","volume":"81","author":"R Rodriguez-Gutierrez","year":"2023","unstructured":"Rodriguez-Gutierrez R, Garcia-Leal M, Raygoza-Cortez K, Flores-Rodr\u00edguez A, Moreno-Alvarado M, Heredia-Mart\u00ednez EM, et al. Benefits and harms of fibrate therapy in patients with type 2 diabetes: a systematic review and meta-analysis. Endocrine. 2023;81(2):231\u201345.","journal-title":"Endocrine"},{"issue":"3","key":"481_CR29","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.ecl.2022.02.011","volume":"51","author":"RB Goldberg","year":"2022","unstructured":"Goldberg RB. Dyslipidemia in diabetes: when and how to treat? Endocrinol Metab Clin North Am. 2022;51(3):603\u201324.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"481_CR30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2015.01.027","volume":"241","author":"Y Appelman","year":"2015","unstructured":"Appelman Y, van Rijn BB, ten Haaf ME, Boersma E, Peters SAE. Sex differences in cardiovascular risk factors and disease prevention. Atherosclerosis. 2015;241(1):211\u20138.","journal-title":"Atherosclerosis"},{"issue":"8","key":"481_CR31","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1007\/s00125-014-3260-6","volume":"57","author":"SA Peters","year":"2014","unstructured":"Peters SA, Huxley RR, Woodward M. Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetologia. 2014;57(8):1542\u201351.","journal-title":"Diabetologia"},{"issue":"9933","key":"481_CR32","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1016\/S0140-6736(14)60040-4","volume":"383","author":"SA Peters","year":"2014","unstructured":"Peters SA, Huxley RR, Woodward M. Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775,385 individuals and 12,539 strokes. Lancet (London England). 2014;383(9933):1973\u201380.","journal-title":"Lancet (London England)"},{"issue":"6","key":"481_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11892-018-1005-5","volume":"18","author":"SAE Peters","year":"2018","unstructured":"Peters SAE, Woodward M. Sex differences in the burden and complications of diabetes. Curr Diab Rep. 2018;18(6):33.","journal-title":"Curr Diab Rep"},{"issue":"1","key":"481_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12902-017-0175-5","volume":"17","author":"SM Shamshirgaran","year":"2017","unstructured":"Shamshirgaran SM, Mamaghanian A, Aliasgarzadeh A, Aiminisani N, Iranparvar-Alamdari M, Ataie J. Age differences in diabetes-related complications and glycemic control. BMC Endocr Disord. 2017;17(1):25.","journal-title":"BMC Endocr Disord"},{"issue":"4","key":"481_CR35","doi-asserted-by":"publisher","first-page":"478","DOI":"10.4103\/0250-474X.164776","volume":"77","author":"S Das","year":"2015","unstructured":"Das S, Haroled Peter PL, Bhavani ML, Naresh P, Ramana MV. Age- and sex-related prevalence and drug utilization pattern in the management of type 2 diabetes mellitus and its comorbidity with cardiovascular diseases: a comparative study. Indian J Pharm Sci. 2015;77(4):478\u201384.","journal-title":"Indian J Pharm Sci"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-023-00481-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40199-023-00481-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-023-00481-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T09:34:05Z","timestamp":1699004045000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40199-023-00481-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,17]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["481"],"URL":"https:\/\/doi.org\/10.1007\/s40199-023-00481-z","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,17]]},"assertion":[{"value":"25 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors confirm that, this work is original and hasn\u2019t been published elsewhere.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}